Skip to content
10-Q

Quarterly Report

RALLYBIO CORPORATION RLYB

0001739410-25-000061

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 41.61M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $14.78M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $13.9M
Current Liabilities Q1 2025 · Mar 31, 2025 $3.91M
Current Liabilities Q1 2025 · Dec 31, 2024 $6.24M
Total Liabilities Q1 2025 · Mar 31, 2025 $3.91M
Total Liabilities Q1 2025 · Dec 31, 2024 $6.45M
Current Assets Q1 2025 · Mar 31, 2025 $57.38M
Current Assets Q1 2025 · Dec 31, 2024 $67.84M
Total Assets Q1 2025 · Mar 31, 2025 $57.98M
Total Assets Q1 2025 · Dec 31, 2024 $68.11M
Shares Diluted Q1 2025 · Mar 31, 2024 40.77M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$15.46M
Stockholders Equity Q1 2025 · Mar 31, 2024 $89.16M
Stockholders Equity Q1 2025 · Dec 31, 2023 $106.18M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.47
Eps Basic Q1 2025 · Mar 31, 2024 −$0.47
Sga Expense Q1 2025 · Mar 31, 2024 $6.85M
Rd Expense Q1 2025 · Mar 31, 2024 $12.94M
Net Income Q1 2025 · Mar 31, 2024 −$19.03M
Operating Income Q1 2025 · Mar 31, 2024 −$19.79M
Revenue Q1 2025 · Mar 31, 2024 $0